SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is currently a focal point for retail investors and long-term community members, with debate intensifying between those speculating on potential future utility and others viewing it as a speculative meme coin. Sentiment remains polarized as users actively debate the impact of ongoing token burn efforts against the significant circulating supply.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems is trending as investors focus on its proprietary wafer-scale AI hardware, which is being highlighted for its ability to deliver record-breaking inference speeds that outperform traditional GPU setups. The community is actively debating the company's aggressive infrastructure expansion and strategic partnerships with major hyperscalers, weighing the long-term potential of its unique architecture against the volatility typical of recent high-profile IPOs.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is seeing intense community focus as traders debate the sustainability of the AI-driven infrastructure boom amidst volatile semiconductor price action and shifting geopolitical risks in the Strait of Hormuz. Investors are actively navigating the leverage-heavy swings of the asset, while divided market sentiment balances cooling inflation data against ongoing debates over potential Federal Reserve rate adjustments.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is trending as investors monitor increased network activity and look for momentum following recent price action across the broader utility token sector. The community remains divided, with long-term holders debating the project's institutional adoption and future price potential versus those expressing frustration over past volatility and dilution.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF is currently experiencing heightened investor attention as market sentiment shifts, driven by significant capital inflows and a potential rotation into Chinese equities. The community remains deeply divided, with some investors betting on a long-term rebound due to attractive valuations and AI advancements, while others remain cautious, citing geopolitical risks and ongoing economic concerns.

Mobileye Global, Inc. engages in the business of developing and deploying driver assistance systems and autonomous driving technologies and solutions. It operates under the Mobileye and Other segments. The company was founded by Amnon Shashua and Ziv Aviram in 1999 and is headquartered in Jerusalem, Israel.

Mobileye Global Inc - Ordinary Shares - Class A

MOBILEYE GLOBAL INC

Mobileye is generating significant buzz as investors debate the potential for a major short squeeze and a long-term re-rating, following strong earnings, a raised revenue forecast, and a new $250 million share buyback program. Community sentiment remains deeply divided between those viewing the stock as a massively undervalued play on robotaxis and autonomous driving, and critics who express skepticism regarding management's robotaxi timeline and the stock's recent volatility.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is seeing significant volatility as the community debates whether the stock is undervalued due to its backlog and AI infrastructure role or if recent insider selling and margin concerns warrant the current downward pressure. Investors are focused on the company's ability to convert major hyperscaler contracts and utility-scale projects into sustained profitability while navigating broader sector weakness and technical consolidation.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors debate the sustainability of its dividend amid revenue declines and stagnant share price performance, while the community actively monitors potential oncology pipeline catalysts like the FDA priority review for Talzenna plus Xtandi. Sentiment remains heavily polarized, with many shareholders expressing frustration over management's leadership and strategic direction, contrasting with others who are positioning for potential long-term value and yield.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.

Cardano

Cardano is experiencing heightened community debate as investors weigh optimistic whale accumulation and technical upgrades against skepticism regarding the project's long-term utility and market relevance. Despite ongoing price volatility, discourse is split between those viewing current levels as a generational accumulation opportunity and others calling for a pivot due to frustrations with the project's competitive positioning.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

e.l.f. Beauty is trending as investors actively discuss its potential as a rebound play, with community members highlighting its strong market share, the successful acquisition of Rhode, and its role as a potential hedge against volatile tech stocks. While short-sellers remain active, many market participants are interpreting the current price levels as a discounted entry point for a long-term growth story.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FDA Accepts BMRN's sNDA Seeking Full Approval for Voxzogo

BioMarin's FDA filing for full Voxzogo approval in achondroplasia has been accepted, with a regulatory decision expected by Feb. 28, 2027.

BridgeBio Stock Taps Rare Disease Trends and New Diagnosis Growth

BBIO builds on Attruby's launch as rising rare disease diagnoses and late-stage pipeline candidates set up multiple potential U.S. launches.

Is BBIO Stock a Buy Now or Too Expensive for the Risk Ahead

BridgeBio Pharma's Attruby sales are surging, but can growth keep justifying its premium valuation amid execution risks and rising costs?

Ascendis Pharma (ASND) Moves 9.9% Higher: Will This Strength Last?

Ascendis Pharma (ASND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

BioMarin's Voxzogo Meets Goal in Late-Stage Study for Hypochondroplasia

BMRN's shares rise after Voxzogo hits the main goal in a late-stage hypochondroplasia study, supporting planned FDA filings in 2026.

Growth Stocks To Keep An Eye On - May 6th

Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, Hercules Capital, Pershing Square, and Trinity Capital are the seven Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow revenues and earnings faster...

Morse Asset Management Inc Purchases Shares of 6,489 Ascendis Pharma A/S $ASND

Morse Asset Management Inc purchased a new stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities...

Growth Stocks To Follow Now - May 4th

Prologis, Pershing Square, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, Hercules Capital, and Tyra Biosciences are the seven Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow their revenues and earnings...

Growth Stocks To Follow Now - May 3rd

Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Acadia Realty Trust are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to increase revenue and earnings faster than the overall market, ofte...

Best Growth Stocks To Consider - May 2nd

Prologis, Teledyne Technologies, and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to...

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.

Ascendis Pharma A/S

Ascendis Pharma Eyes Best Open In A Month After Q4 Print, But BofA Cuts Price Target: Retail Gets Buzzing

Equity

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards another losing week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

ASNDAscendis Pharma

Latest ASND News